✦ LIBER ✦

The trifunctional antibody catumaxomab in treatment of malignant ascites and peritoneal carcinomatosis

✍ Scribed by Ströhlein, Michael A; Heiss, Markus M

Book ID: 124069258
Publisher: Future Medicine
Year: 2010
Tongue: English
Weight: 616 KB
Volume: 6
Category: Article
ISSN: 1479-6694
DOI: 10.2217/fon.10.111

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The trifunctional antibody catumaxomab f

The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial

✍ Markus M. Heiss; Pawel Murawa; Piotr Koralewski; Elzbieta Kutarska; Olena O. Kol 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 559 KB

## Abstract Malignant ascites is a common manifestation of advanced cancers, and treatment options are limited. The trifunctional antibody catumaxomab (anti‐epithelial cell‐adhesion molecule x anti‐CD3) represents a targeted immunotherapy for the intraperitoneal (i.p.) treatment of malignant ascite

5001 ORAL Intraperitoneal administration

5001 ORAL Intraperitoneal administration of the trifunctional antibody catumaxomab for treatment of malignant ascites due to ovarian carcinoma: Results of a phase II/III study

✍ Parsons, S.; Kutarska, E.; Koralewski, P.; Gore, M.; Wimberger, P.; Burges, A.; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 60 KB

659 POSTER Intraperitoneal application o

659 POSTER Intraperitoneal application of the trifunctional antibody catumaxomab (anti-EpcAM x anti-CD3) for the treatment of peritoneal carcinomatosis due to GI cancer: Results of a phase I trial

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 279 KB

Intraperitoneal immunotherapy with trifu

Intraperitoneal immunotherapy with trifunctional antibodies: a new concept for treatment of peritoneal carcinomatosis in patients with GI-tract cancer

✍ Michael A. Stroehlein; Uwe Gruetzner; Anwar Tarabichi; Michael Jaeger; Horst Lin 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Laparoscopic hyperthermic intraperitonea

Laparoscopic hyperthermic intraperitoneal chemotherapy (HIPEC) for the treatment of malignant ascites secondary to unresectable peritoneal carcinomatosis from advanced gastric cancer

✍ E. Facchiano; S. Scaringi; R. Kianmanesh; J.M. Sabate; B. Castel; Y. Flamant; B. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 137 KB

The contribution of catumaxomab in the t

The contribution of catumaxomab in the treatment of malignant ascites in patients with ovarian cancer: a review of the literature

✍ Panagiotis Tsikouras, Nikolaos Tsagias… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 158 KB